(Q52665964)

5 May 2018

title

Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. (English)

1 reference

5 May 2018

0 references

1 reference

1

1 reference

5 May 2018

author name string

Karen Dempsey

series ordinal

2

1 reference

5 May 2018

James S McCarthy

series ordinal

3

1 reference

5 May 2018

publication date

23 March 2006

1 reference

5 May 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

5 May 2018

volume

100

1 reference

5 May 2018

issue

11

1 reference

5 May 2018

page(s)

1056-1062

1 reference

5 May 2018

Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect Elisa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Seroepidemiology of strongyloidiasis in a Thai village

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Comparative sensitivity and specificity of ELISA and IHA for serodiagnosis of strongyloidiasis with larval antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Coproantigen detection in rats experimentally infected with Strongyloides ratti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Chronic strongyloidiasis in World War II Far East ex-prisoners of war

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Molecular differences between several species of Strongyloides and comparison of selected isolates of S. stercoralis using a polymerase chain reaction-linked restriction fragment length polymorphism approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Serodiagnosis of strongyloidiasis. The application and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Efficacy of stool examination for detection of Strongyloides infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Fluctuations of larval excretion in Strongyloides stercoralis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

inferred from DOI database lookup

7 January 2021

based on heuristic

A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2005.12.006

1 reference

5 May 2018

PubMed ID

16551471

1 reference

5 May 2018